Fortis Healthcare valuation

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Price multiples — at each FY-end close
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
51.22×————
5.42×————
5.65×————
81.79×————
Enterprise multiples
5.93×————
26.46×————
33.94×————
Yield
2.0%————
1.2%————
Reference — adjusted share basis
₹711.00————
₹13.88₹13.80₹10.25₹7.93₹7.80
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

FORTIS₹711.00

Fortis Healthcare Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPMAXHEALTHMEDANTAAUROPHARMALUPINALKEMLAURUSLABSMANKINDMcap ₹53,678 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Price Multiples — at each FY-end close
P/E————51.22
P/B————5.42
P/Sales————5.65
Price to Free Cash Flow————81.79
Enterprise Multiples
EV/Sales————5.93
EV/EBITDA————26.46
EV/EBIT————33.94
Yield
Earnings Yield %————1.95
FCF Yield %————1.22
Reference — adjusted share basis
Price (FY-end close, adj.)————711.00
EPS (adj.)7.807.9310.2513.8013.88
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.